Nefrosol Kálium B. Braun Avitum (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

Sodium Hydrogen Carbonate supplies bicarbonate ions that act as a physiological buffer, helping to raise blood pH toward normal levels. Together with potassium, magnesium, calcium, and sodium ions, it restores the electrolyte composition of plasma, supporting cellular function and maintaining hemodynamic stability.

The dose of Nefrosol Kálium is individualized by the prescribing clinician based on the patient’s electrolyte status, acid‑base balance, and clinical condition. The healthcare professional determines the infusion volume, rate, and duration according to laboratory values and therapeutic goals.

The safety of Nefrosol Kálium in pregnancy or lactation has not been definitively established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician after careful assessment.

To order Nefrosol Kálium, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nefrosol Kálium provides a balanced combination of sodium, potassium, magnesium, calcium, and bicarbonate, making it suitable for a broad range of electrolyte and acid‑base disorders. Compared with simpler saline solutions, it offers additional ions that can correct metabolic acidosis and support cardiac and neuromuscular function without the need for multiple separate infusions.

Store Nefrosol Kálium at ambient temperature, preferably below 25 °C. Keep the container sealed, protect it from direct sunlight, and avoid exposure to moisture. Do not freeze the solution, and use it before the expiration date indicated on the packaging.

Nefrosol Kálium is administered intravenously. The solution is infused through a sterile IV line, typically using an infusion pump or controlled drip to achieve the prescribed rate. Administration should occur under clinical supervision with regular monitoring of vital signs and electrolyte levels.

Serious risks include severe hyperkalemia or hypermagnesemia, which can cause cardiac arrhythmias or respiratory depression, as well as anaphylactic reactions and rapid fluid overload leading to pulmonary edema. Prompt recognition of symptoms and immediate medical intervention are essential if these events occur.

Patients with known hypersensitivity to any component of the solution, uncontrolled hyperkalemia, severe renal failure without appropriate monitoring, or those at high risk for fluid overload (e.g., severe heart failure) should not receive Nefrosol Kálium unless a physician determines that benefits outweigh the risks.